Sanofi (SNY) reported Q2 earnings Thursday of 3.24 euros ($3.71) per share, up from 0.89 euro a year earlier.

Net sales for the quarter ended June 30 were 9.99 billion euros, up from 9.43 billion euros a year earlier.

For 2025, the company said it now expects sales to grow by a high single-digit percentage at CER versus its prior outlook of mid-to-high single-digit.

Sanofi shares were down 4.6% in recent premarket activity.